PROS1
protein-codingprotein S, the group of Gla domain containing
Gene summary
This gene encodes a vitamin K-dependent plasma protein that functions as a cofactor for the anticoagulant protease, activated protein C (APC) to inhibit blood coagulation. It is found in plasma in both a free, functionally active form and also in an inactive form complexed with C4b-binding protein. Mutations in this gene result in autosomal dominant hereditary thrombophilia. An inactive pseudogene of this locus is located at an adjacent region on chromosome 3. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Oct 2015]
- PROS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~107.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019144
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013791
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013791
Submitter: Ambry Genetics
Inheritance Pattern: SD
Disease ID:MONDO:0002304
Submitter: ClinGen
PROS1 was first reported in relation to semidominant protein S deficiency in 1994 (Hayashi T, et al., 1994, PMID: 8298131). Over 400 unique variants (including missense, nonsense, splicing and frameshift variants) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 18 probands in 5 publications (PMIDs: 8298131, 10063989, 7545463, 20484936, 10447256). Variants in this gene segregated with disease in 33 additional family members. More evidence is available in the literature, but the maximum score for genetic and experimental evidence has been reached. This gene-disease relationship is supported by its biochemical function as a cofactor for Protein C (PMID: 6892911), and both heterozygous and null mouse models which recapitulate phenotypes observed in humans (PMID: 19567881). In summary, PROS1 is definitively associated with semidominant protein S deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0012868
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013791
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012868
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013791
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0012868
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: SD
Disease ID:MONDO:0012868
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012868
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Individuals may be at higher risk for thrombophilia, and may demonstrate thrombosis and secondary hemorrhage usually beginning in early infancy (in recessive forms); Prompt recognition may allow preventive measures and early treament, which may reduce morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PROS1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000313.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 95 | 1 | 105 | |
| missense | 8 | 53 | 253 | 13 | 327 | |
| nonsense | 23 | 7 | 30 | |||
| start loss | 3 | 1 | 4 | |||
| frameshift | 18 | 19 | 2 | 39 | ||
| splice donor/acceptor (+/-2bp) | 10 | 24 | 4 | 38 | ||
| Total | 62 | 105 | 267 | 108 | 1 | 543 |
Highest pathogenic variant AF is 0.0005702668
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000304.2 | 15 | MANE Select | |
| Ensembl | ENSP00000377783.3 | 15 | MANE Select | |
| RefSeq | NP_001301006.1 | 16 | Standard | |
| Ensembl | ENSP00000330021.7 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Complement and coagulation cascades - Homo sapiens (human)
- Warfarin Pathway, Pharmacodynamics
- Human Complement System
- Dengue-2 Interactions with Complement and Coagulation Cascades
- Complement and Coagulation Cascades
Biological Process
- platelet degranulation
- endoplasmic reticulum to Golgi vesicle-mediated transport
- blood coagulation
- negative regulation of endopeptidase activity
- regulation of complement activation
Molecular Function
- endopeptidase inhibitor activity
- calcium ion binding
Cellular Component
- Golgi membrane
- extracellular region
- extracellular space
- endoplasmic reticulum membrane
- Golgi lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000394236
- Coding exons
- 15
- Length
- 101030
- Individuals with no LoFs
- 125730
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125748
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.585 | 335 | 366 | 0.914 | 0.0000186 | 4443 |
| Missense (PolyPhen) | 89 | 129.27 | 0.68849 | 1607 | ||
| Synonymous | 0.110 | 129 | 131 | 0.988 | 0.00000667 | 1266 |
| Loss of Function | 3.49 | 12 | 34.0 | 0.353 | 0.00000153 | 454 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000088 | 0.000088 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis.;
- Disease
- DISEASE: Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]: A hemostatic disorder characterized by impaired regulation of blood coagulation and a tendency to recurrent venous thrombosis. Based on the plasma levels of total and free PROS1 as well as the serine protease-activated protein C cofactor activity, three types of THPH5 have been described: type I, characterized by reduced total and free PROS1 levels together with reduced anticoagulant activity; type III, in which only free PROS1 antigen and PROS1 activity levels are reduced; and the rare type II which is characterized by normal concentrations of both total and free PROS1 antigen, but low cofactor activity. {ECO:0000269|PubMed:10447256, ECO:0000269|PubMed:10613647, ECO:0000269|PubMed:10706858, ECO:0000269|PubMed:10790208, ECO:0000269|PubMed:11372770, ECO:0000269|PubMed:11776305, ECO:0000269|PubMed:11858485, ECO:0000269|PubMed:11927129, ECO:0000269|PubMed:12351389, ECO:0000269|PubMed:12632031, ECO:0000269|PubMed:15238143, ECO:0000269|PubMed:15712227, ECO:0000269|PubMed:18322254, ECO:0000269|PubMed:7482398, ECO:0000269|PubMed:7545463, ECO:0000269|PubMed:7579449, ECO:0000269|PubMed:7803790, ECO:0000269|PubMed:8298131, ECO:0000269|PubMed:8639833, ECO:0000269|PubMed:8701404, ECO:0000269|PubMed:8765219, ECO:0000269|PubMed:8781426, ECO:0000269|PubMed:8943854, ECO:0000269|PubMed:8977443, ECO:0000269|PubMed:9031443, ECO:0000269|PubMed:9241758, ECO:0000269|Ref.15}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Thrombophilia due to protein S deficiency, autosomal recessive (THPH6) [MIM:614514]: A very rare and severe hematologic disorder resulting in thrombosis and secondary hemorrhage usually beginning in early infancy. Some affected individuals develop neonatal purpura fulminans, multifocal thrombosis, or intracranial hemorrhage. {ECO:0000269|PubMed:20484936}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.427
Intolerance Scores
- LoFtool
- 0.270
- RVIS EVS
- -0.22
- RVIS percentile EVS
- 37.6
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.457
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |